BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 16505208)

  • 1. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
    Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
    Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
    Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone.
    Funder JW
    Hypertension; 2006 Apr; 47(4):634-5. PubMed ID: 16505209
    [No Abstract]   [Full Text] [Related]  

  • 6. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
    Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
    Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T
    Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.
    Kimura S; Ito M; Tomita M; Hoyano M; Obata H; Ding L; Chinushi M; Hanawa H; Kodama M; Aizawa Y
    Hypertens Res; 2011 May; 34(5):584-91. PubMed ID: 21248754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N; Hara K; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
    Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
    Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
    Arai K; Tsuruoka H; Homma T
    Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
    Zhu A; Yoneda T; Demura M; Karashima S; Usukura M; Yamagishi M; Takeda Y
    J Hypertens; 2009 Apr; 27(4):800-5. PubMed ID: 19516179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
    Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
    Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
    Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
    Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.